Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial
J. Bruce McClain, Ariel Chuang, Caroline Reid, Susan M. Moore, Eric Tsao
Topics & Concepts
Rabies virusRabiesRegimenRabies vaccineImmunogenicityVaccinationMedicineNeutralizing antibodyClinical endpointRandomized controlled trialPharmacokineticsAdverse effectAntibodyVirologyInternal medicineImmunologyPharmacologyRabies epidemiology and controlVenomous Animal Envenomation and StudiesBacillus and Francisella bacterial research